VIVOSTAT A/S: Financial statements 2023
CVR: 10033365
Source: annual report 2023, Danish Business Authority
01/05/2022 – 30/04/2023
VIVOSTAT A/S (CVR 10033365) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 13,468,214 and a net result of DKK 4,899,048 compared with DKK 5,668,024 the year before. That is a decrease of 2.7% compared with the year before. Equity in the 2023 report amounted to DKK 24,342,793. The solvency ratio was 91.9%. The company had 9 employees in the financial year.
- Gross Profit
- DKK 13,468,214
- Profit/Loss
- DKK 4,899,048
- Equity
- DKK 24,342,793
- Total Assets
- DKK 26,498,850
- Employees
- 9
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 13.5M | 4.9M | 24.3M | 9 |
| 2022 | - | 13.8M | 5.7M | 24.4M | 10 |
| 2021 | - | 5.4M | -2.5M | 18.8M | 10 |
| 2020 | - | 11.3M | 3.4M | 21.2M | 10 |
| 2019 | - | 11.6M | 2.3M | 19.3M | 9 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout VIVOSTAT A/S
VIVOSTAT A/S is a Danish company of the type Aktieselskab based in Allerød, founded in 2000. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named VIVOLUTION A/S. The management consists of Marko Rackovic. The board consists of Dr. Peter Leopold Maier (chair), Marko Rackovic and Viktor Alexander Maier. The company is owned by Vivostat International GmbH. The company has 10 employees (2026). In 2026, the company reported a gross profit of DKK 13,966,645 and a net result of DKK 1,466,266 compared with DKK 3,338,866 the year before. Equity in the 2026 report amounted to DKK 28,750,729.